Randomised, placebo-controlled study of efficacy and safety of CTX cells in subjects with disability following ischaemic stroke (PISCES III).

Clinical Trial Stage: Phase IIb

Trial Purpose: To assess the efficacy of intracerebral CTX0E03 DP by change in degree of dependency and disability from baseline, as measured by modified Rankin Score (mRS).

Status : Recruiting (please click here to access the trial website www.pisces3.org)

Efficacy study of CTX cells in patients with stable paresis of the arm following an ischaemic stroke

Clinical Trial Stage: Phase II

Trial Purpose: To determine if treatment at a dose of 20m cells improves recovery in use of paretic arm in stroke patients to justify a larger pivotal study

Status : Data Reported

PISCES safety study of CTX cells in the treatment of patients with stable ischaemic stroke

Clinical Trial Stage: Phase I

Trial Purpose: To test safety of CTX cells delivered by injection into the damaged brains of male patients > 60 left moderately to severely disabled 6 months to 5 years following an ischaemic stroke

Status : Study completed

Open label prospective study of the safety and tolerability of the human retinal progenitor cell (hRPC) therapy candidate in the treatment of patients with retinitis pigmentosa

Clinical Trial Stage: Phase I/IIa

Trial Purpose: To evaluate the safety, tolerability and preliminary efficacy of sub-retinally transplanted hRPCs in patients with advanced retinitis pigmentosa.

Next milestone: Read out in mid-2019

Non-interventional, observational study for patients with stable ischaemic stroke to document clinical course and establish pool of patients for on-going trials

Clinical Trial Stage: Observational

Trial Purpose: To build data set in untreated disabled stroke patients and facilitate on-going clinical trials

Next milestone: Study completed

Ascending dose safety study of CTX cells in patients with lower limb ischaemia

Clinical Trial Stage: Phase I

Trial Purpose: To investigate the safety and tolerability of intramuscular injections of CTX cells in patients with peripheral arterial disease

Next milestone: Study completed


Further information regarding our clinical trials, including relevant contact details, may be found on clinicaltrials.gov, a registry of clinical trials providing patients, family members, and members of the public free and easy access to information on clinical studies for a wide range of diseases and conditions: please click here.